VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASCO 2022 | Managing adverse events associated with TKIs in CML

Jorge Cortes, MD, Georgia Cancer Center, Augusta, GA, discusses the management of adverse events associated with the use of tyrosine kinase inhibitors (TKIs) in patients with chronic myeloid leukemia (CML), such as dose adjustments associated with pleural effusions or elevation of transaminases. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter